EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes

Fatima Sulaiman, Costerwell Khyriem iD, Stafny Dsouza iD, Fatima Abdul, Omer Alkhnbashi iD, Hanan Faraji, Muhammad Farooqi iD, Fatheya Al Awadi iD, Mohammed Hassanein, Fayha Ahmed iD, Mouza Alsharhan, Abdel Rahman Tawfik und 2 weitere

International Journal of Molecular Sciences · 14.01.2025 · 26 (2) · 637

DOI: 10.3390/ijms26020637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.01.2025. Verfasst von Fatima Sulaiman und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Circulating MicroRNA, MicroRNAs. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sandooq Al Watan, COLLEGE OF MEDICINE, MOHAMMED BIN RASHID UNIVERSITY OF MEDICINE AND HEALTH SCIENCES (MBRU), SANDOOQ AL WATAN LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously reported five clinical subtypes that characterize the underlying pathophysiology of long-standing T2D: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and mild early-onset diabetes (MEOD). We analyzed the circulating microRNAs (miRNAs) in 45 subjects representing the five T2D clusters and 7 non-T2D healthy controls by single-end small RNA sequencing. Bioinformatic analyses identified a total of 430 known circulating miRNAs and 13 previously unreported novel miRNAs. Of these, 71 were upregulated and 37 were downregulated in either controls or individual clusters. Each T2D subtype was associated with a specific dysregulated miRNA profile, distinct from that of healthy controls. Specifically, 3 upregulated miRNAs were unique to SIRD, 1 to MARD, 9 to MOD, and 18 to MEOD. Among the downregulated miRNAs, 11 were specific to SIRD, 9 to SIDD, 2 to MARD, and 1 to MEOD. Our study confirms the heterogeneity of T2D, represented by distinguishable subtypes both clinically and epigenetically and highlights the potential of miRNAs as markers for distinguishing the pathophysiology of T2D subtypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Circulating MicroRNAMicroRNAsHumansMaleFemaleMiddle AgedGene Expression ProfilingAgedAdultBiomarkersCase-Control StudiesTranscriptomeInsulin ResistanceComputational Biology

Stichwörter der Autor:innen

T2D subtypesType 2 diabetescirculating microRNAinsulin resistancepathophysiology

Substanzen

Circulating MicroRNABiomarkersMicroRNAs

Autor:innen und Institutionen

  • College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.
  • Center for Applied and Translational Genomics, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.
  • Dubai Diabetes Center, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates.
  • Endocrinology Department, Dubai Hospital, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates.
  • Pathology Department, Dubai Hospital, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates.
  • Hamdan Bin Mohammed College of Dental Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.

ORCID-Profile: Costerwell Khyriem, Stafny Dsouza, Omer Alkhnbashi, Muhammad Farooqi, Fatheya Al Awadi, Fayha Ahmed, Amar Hassan Khamis, Riad Bayoumi

Förderung

  • Sandooq Al Watan
  • COLLEGE OF MEDICINE, MOHAMMED BIN RASHID UNIVERSITY OF MEDICINE AND HEALTH SCIENCES (MBRU)
  • SANDOOQ AL WATAN LLC
  • MBRU

Zitieren

APA

Sulaiman, F., Khyriem, C., Dsouza, S., Abdul, F., Alkhnbashi, O., Faraji, H., Farooqi, M., Al Awadi, F., Hassanein, M., Ahmed, F., Alsharhan, M., Tawfik, A. R., Khamis, A. H., & Bayoumi, R. (2025). Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes. International Journal of Molecular Sciences, 26(2), 637. https://doi.org/10.3390/ijms26020637

Vancouver

Sulaiman F, Khyriem C, Dsouza S, Abdul F, Alkhnbashi O, Faraji H, et al. Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes. International Journal of Molecular Sciences. 2025;26(2):637. doi:10.3390/ijms26020637

BibTeX
@article{Sulaiman2025,
  author = {Sulaiman, Fatima and Khyriem, Costerwell and Dsouza, Stafny and Abdul, Fatima and Alkhnbashi, Omer and Faraji, Hanan and Farooqi, Muhammad and Al Awadi, Fatheya and Hassanein, Mohammed and Ahmed, Fayha and Alsharhan, Mouza and Tawfik, Abdel Rahman and Khamis, Amar Hassan and Bayoumi, Riad},
  title = {Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {2},
  pages = {637},
  doi = {10.3390/ijms26020637}
}
Kostenlos starten →